{"transactions":[{"id":2916374,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-06T22:02:38.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":105693,"price":2.71,"value":286428.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.52 to $2.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1799280,"source":{"system":"sec-edgar","filing":"0001209191-21-002171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121002171/doc4.xml","form_type":"4"}},{"id":3296864,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-31T21:45:20.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":264200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2019."}],"balance_after":264200,"derivative":{"exercise_price":4.21,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":264200},"source":{"system":"sec-edgar","filing":"0001209191-20-005780","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120005780/doc4.xml","form_type":"4"}},{"id":3296863,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-31T21:45:20.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":171700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"57,234 shares shall vest on 12/31/2020 and 57,233 shares shall vest on each of 12/31/2021 and 12/31/2022."}],"balance_after":1904973,"source":{"system":"sec-edgar","filing":"0001209191-20-005780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120005780/doc4.xml","form_type":"4"}},{"id":3329175,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-12-31T21:37:32.000Z","date":"2019-12-27","kind":"exercise","acquired":false,"shares":44642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2018."}],"balance_after":487171,"derivative":{"exercise_price":2.24,"expiration_date":"2029-01-06","underlying":"Common Stock","underlying_shares":44642},"source":{"system":"sec-edgar","filing":"0001209191-19-062290","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119062290/doc4.xml","form_type":"4"}},{"id":3329174,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-12-31T21:37:32.000Z","date":"2019-12-30","kind":"sale","acquired":false,"shares":110694,"price":4.88,"value":540186.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.79 to $5.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1733273,"source":{"system":"sec-edgar","filing":"0001209191-19-062290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119062290/doc4.xml","form_type":"4"}},{"id":3329173,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-12-31T21:37:32.000Z","date":"2019-12-27","kind":"exercise","acquired":true,"shares":44642,"price":2.24,"value":99998.08,"ownership":{"direct":true},"balance_after":1843967,"source":{"system":"sec-edgar","filing":"0001209191-19-062290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119062290/doc4.xml","form_type":"4"}},{"id":3700899,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-08T21:24:37.000Z","date":"2019-01-06","kind":"grant","acquired":true,"shares":531813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2018."}],"balance_after":531813,"derivative":{"exercise_price":2.24,"expiration_date":"2029-01-06","underlying":"Common Stock","underlying_shares":531813},"source":{"system":"sec-edgar","filing":"0001209191-19-002778","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119002778/doc4.xml","form_type":"4"}},{"id":3700898,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-08T21:24:37.000Z","date":"2019-01-06","kind":"tax_withholding","acquired":false,"shares":165178,"price":2.24,"value":369998.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grant."}],"balance_after":1799325,"source":{"system":"sec-edgar","filing":"0001209191-19-002778","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119002778/doc4.xml","form_type":"4"}},{"id":3700897,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-08T21:24:37.000Z","date":"2019-01-06","kind":"grant","acquired":true,"shares":446428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the Issuer's option plan, the Reporting Person elected to receive fully vested shares of Common Stock in lieu of a cash bonus."}],"balance_after":1964503,"source":{"system":"sec-edgar","filing":"0001209191-19-002778","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119002778/doc4.xml","form_type":"4"}},{"id":3700896,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-08T21:24:37.000Z","date":"2019-01-06","kind":"grant","acquired":true,"shares":337266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"112,422 shares shall vest on each of 12/31/2019, 12/31/2020 and 12/31/2021."}],"balance_after":1518075,"source":{"system":"sec-edgar","filing":"0001209191-19-002778","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119002778/doc4.xml","form_type":"4"}},{"id":3714462,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-03T02:15:32.000Z","date":"2018-12-31","kind":"tax_withholding","acquired":false,"shares":16156,"price":1.87,"value":30211.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":1180809,"source":{"system":"sec-edgar","filing":"0001209191-19-000586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119000586/doc4.xml","form_type":"4"}},{"id":3714461,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-03T02:15:32.000Z","date":"2018-12-30","kind":"tax_withholding","acquired":false,"shares":26178,"price":1.66,"value":43455.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":1196965,"source":{"system":"sec-edgar","filing":"0001209191-19-000586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119000586/doc4.xml","form_type":"4"}},{"id":3714460,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-03T02:15:32.000Z","date":"2018-12-29","kind":"tax_withholding","acquired":false,"shares":42920,"price":1.66,"value":71247.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":1223143,"source":{"system":"sec-edgar","filing":"0001209191-19-000586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919119000586/doc4.xml","form_type":"4"}},{"id":3918947,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-24T21:11:28.000Z","date":"2018-05-05","kind":"tax_withholding","acquired":false,"shares":123333,"price":4.41,"value":543898.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":1266063,"source":{"system":"sec-edgar","filing":"0001209191-18-033067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919118033067/doc4.xml","form_type":"4"}},{"id":4113044,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-01-03T21:54:58.000Z","date":"2017-12-31","kind":"tax_withholding","acquired":false,"shares":16157,"price":4.14,"value":66889.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":1389396,"source":{"system":"sec-edgar","filing":"0001209191-18-000993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919118000993/doc4.xml","form_type":"4"}},{"id":4113043,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-01-03T21:54:58.000Z","date":"2017-12-30","kind":"tax_withholding","acquired":false,"shares":26178,"price":4.14,"value":108376.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":1405553,"source":{"system":"sec-edgar","filing":"0001209191-18-000993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919118000993/doc4.xml","form_type":"4"}},{"id":4113042,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-01-03T21:54:58.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":348000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"116,000 shares shall vest on each of 12/29/2018, 12/29/2019 and 12/29/2020."}],"balance_after":1431731,"source":{"system":"sec-edgar","filing":"0001209191-18-000993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919118000993/doc4.xml","form_type":"4"}},{"id":4167897,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-11-09T21:43:19.000Z","date":"2017-11-08","kind":"purchase","acquired":true,"shares":6440,"price":4.68,"value":30139.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.66 to $4.71, inclusive.The Reporting Person undertakes to provide to the Issuer, any stockholder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":1083731,"source":{"system":"sec-edgar","filing":"0001209191-17-059988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919117059988/doc4.xml","form_type":"4"}},{"id":4328564,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-09T22:50:49.000Z","date":"2017-05-05","kind":"tax_withholding","acquired":false,"shares":132000,"price":7.12,"value":939840.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of a restricted stock grant."}],"balance_after":1077291,"source":{"system":"sec-edgar","filing":"0001209191-17-031086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919117031086/doc4.xml","form_type":"4"}},{"id":4503586,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-04T21:41:10.000Z","date":"2016-12-31","kind":"tax_withholding","acquired":false,"shares":17292,"price":5.35,"value":92512.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":1209291,"source":{"system":"sec-edgar","filing":"0001209191-17-000996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919117000996/doc4.xml","form_type":"4"}},{"id":4503585,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":144096,"kind":"person","name":"Cooper Laurence James Neil","position":1,"cik":"0001641506","reported_name":"Cooper Laurence James Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-04T21:41:10.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":212250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"70,750 shares vest on each of 12/30/2017, 12/30/2018 and 12/30/2019."}],"balance_after":1226583,"source":{"system":"sec-edgar","filing":"0001209191-17-000996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919117000996/doc4.xml","form_type":"4"}}]}